Model‐Informed Drug Development Supports Full Approval of Ibuprofen Injection in Chinese Pediatric Patients With Fever or Pain

Documenti analoghi

• Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
  di: Ian T.T. Liu, et al.
  Pubblicazione: (2026)
• Extended Model‐Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
  di: Mohamed A. Kamal, et al.
  Pubblicazione: (2024)
• Dose Determinations at Drug Approval Reviews: FDA‐Approved Drugs in Past 5 Years
  di: Sachiko Mita, et al.
  Pubblicazione: (2025)
• Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
  di: Yow‐Ming C. Wang, et al.
  Pubblicazione: (2024)
• Model‐Informed Drug Development‐Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial Spondyloarthritis
  di: Thomas Dumortier, et al.
  Pubblicazione: (2025)